Expand DYAI Menu
DYAI MENU

DYAI Latest Press Releases

-- March 25, 2026 --

Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress Globe Newswire 4:51 PM

-- March 16, 2026 --

Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices Globe Newswire 7:20 AM

-- March 13, 2026 --

Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing Globe Newswire 8:35 AM

-- March 11, 2026 --

Dyadic to Report 2025 Full Year Financial Results and Host Conference Call on Wednesday, March 25, 2026 Globe Newswire 4:10 PM

-- March 10, 2026 --

Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th Globe Newswire 10:21 AM

-- March 4, 2026 --

Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free) Globe Newswire 7:20 AM

-- March 2, 2026 --

Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Development Milestone Globe Newswire 7:20 AM

-- February 17, 2026 --

Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch of Recombinant Human Albumin Globe Newswire 7:25 AM

-- December 23, 2025 --

Santa's Rally: CMCT, SURG, SIDU, MYSE, AZI - Stocks Under $5 to Watch Now - More Inside AB Digital Inc 12:57 PM

-- December 17, 2025 --

Dyadic and Fermbox Bio Expand Strategic Collaboration to Accelerate Commercialization of Animal-Free Proteins and Enzymes Across Life Science, Food & Nutrition, and Bioindustrial Markets Globe Newswire 7:20 AM

-- December 15, 2025 --

Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic's Recombinant Growth Factors and Media Proteins Globe Newswire 7:20 AM

-- December 1, 2025 --

Dyadic and BRIG BIO Sign Development & Commercialization Agreement to Bring Animal-Free Bovine Alpha-Lactalbumin to Global Nutrition Markets Globe Newswire 7:25 AM

-- November 12, 2025 --

Dyadic Announces Third Quarter 2025 Financial Results and Highlights Strategic Progress Globe Newswire 4:05 PM

-- November 10, 2025 --

Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics Globe Newswire 7:25 AM
Market Data Delayed 15 Minutes